Verseon Corporation Additional Listing & Total Voting Rights (3082D)
June 25 2019 - 2:01AM
UK Regulatory
TIDMVERS
RNS Number : 3082D
Verseon Corporation
25 June 2019
June 25, 2019
Verseon Corporation
("Verseon" or the "Company")
Additional Listing & Total Voting Rights
Fremont, Calif.-Verseon, a technology-based pharmaceutical
company, announces that application has been made for 158,042
common shares of par value $0.001 each ("Common Shares") to be
admitted to trading on AIM pursuant to option exercise of 5,542
common shares as well as regularly scheduled vesting of restricted
stock units and restricted stock awards of 152,500 common shares
(the "Issuance").
The 158,042 new Common Shares issued pursuant to the Issuance
will rank pari passu with the Company's existing Common Shares and
admission to trading on AIM is expected to take place on June 28,
2019 ("Admission").
Total Voting Rights
Following Admission, the issued share capital of the Company
will consist of 159,729,429 Common Shares and the Company will hold
42,917 shares in treasury. Therefore, the total number of Common
Shares in the Company with voting rights will be 159,686,512. This
figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's
Disclosure and Transparency Rules.
-Ends-
For further information please contact:
Verseon Corporation www.verseon.com
+1 (510) 225
Sebastian Wykeham / Tina Schlafly 9000
Arden Partners (NOMAD and Joint Broker)
Ruari McGirr / Ciaran Walsh / Dan Gee-Summons
(Corporate Finance) / +44 (0) 20 7614
Fraser Marshall (Equity Sales) 5900
Cantor Fitzgerald Europe (Joint Broker)
+44 (0) 20 7894
Phil Davies 7000
For financial and business media enquiries, please contact
Buchanan Communications Ltd (PR Advisors)
Henry Harrison-Topham / Jamie Hooper +44 (0) 20 7466 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
Simon Vane Percy +44 (0) 1737 821 89
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCEALKSAEENEEF
(END) Dow Jones Newswires
June 25, 2019 02:01 ET (06:01 GMT)
Verseon (LSE:VERS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verseon (LSE:VERS)
Historical Stock Chart
From Jul 2023 to Jul 2024